Free U.S. shipping $175+

PT-141 — Novaryn Research
Hover to zoom
MelanocortinSynthetic cyclic heptapeptide (melanocortin analog)

PT-141

$39.99
10 mg

PT-141 (bremelanotide) is a cyclic melanocortin peptide derived from the Melanotan II scaffold, modified to shift its receptor preference toward MC4R.

Because MC4R is expressed predominantly in the central nervous system and is studied in relation to appetite and behavior pathways, this compound is used in preclinical research examining central melanocortin signaling rather than peripheral pigmentation.

Research areas
MC4R receptor signalingCentral melanocortin pathwaysReceptor selectivity studiesPreclinical research
Form: Lyophilized (freeze-dried)
Compound class
Synthetic cyclic heptapeptide (melanocortin analog)
Research category
Melanocortin
SKU
NVR-PT-141-10MG
Alternate name
Bremelanotide
CAS
189691-06-3
Appearance
White lyophilized powder
Storage
Store lyophilized at −20 °C. Protect from light and moisture.
Research use only
Strength
10 mg$39.99$4.00/mg
1
$39.99per 10 mg$4.00/mg

For research use only — not for human or animal consumption.

Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.

Research Grade
Batch Documentation
Research Use Only
U.S.-Based Fulfillment
What you should know

More detail on PT-141.

Analytical values reflect per-lot documentation and appear once a batch is released.

Compound
Shifting selectivity within the melanocortin family is chemically difficult because the receptor subtypes share a conserved binding pocket. PT-141 represents a documented case of that shift and is therefore of interest both as a pharmacological tool and as a medicinal-chemistry example. Laboratory applications include MC4R-expressing cell assays measuring cyclic-AMP response, comparative selectivity panels across the receptor family, and preclinical neuroscience models of central melanocortin signaling. Not for human use.
Peptide class
Synthetic cyclic heptapeptide (melanocortin analog)
Mechanism (research context)
PT-141 is characterized as a melanocortin receptor agonist with reported selectivity favoring MC3R/MC4R engagement, used in receptor-pharmacology research.
Why it is studied
It is a defined-sequence reference compound in the melanocortin analog pharmacology literature.
Current areas of research
MC4R receptor signalingCentral melanocortin pathwaysReceptor selectivity studiesPreclinical research

Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.

Scientific background

PT-141 emerged from the Melanotan II series with modifications that shifted its receptor-selectivity profile away from MC1R-dominant activity.

It has since been used as a comparison peptide in melanocortin-selectivity research.

Related

Related research materials

View all →
PT-141
10 mg · $39.99
Notify me when available